Elevation Pharmaceuticals Announces Positive Phase 2b Results for EP-101 for the Treatment of Chronic Obstructive ...

SAN DIEGO, May 16, 2012 /PRNewswire/ -- Elevation Pharmaceuticals, Inc., a pharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today ...

Many to climb Austin skyscraper for lung disease

Lung disease is something that affects everyone at some point in their life, whether it's asthma, bronchitis or lung cancer. This weekend hundreds will hit the stairs inside one of Austin's tallest buildings to help in the prevention, control and cure of lung disease. Miss Austin, Callie Thompson, and chair of the Fight for Air Climb, Mary Partridge ,spoke to KVUE about the event. It will take ...

CDC to baby boomers: Get tested for hepatitis C

For the first time, the government is proposing that all baby boomers get tested for hepatitis C.

Emphysema (COPD)

MANILA, Philippines --- EMPHYSEMA is a form of chronic obstructive pulmonary disease (COPD) caused by loss of elasticity and dilatation of the lung tissue. In emphysema the lungs become less and less efficient because of progressive damage to the millions of alveoli, or air sacs, at the ends of the bronchioles in the lungs. Oxygen and carbon dioxide exchange takes place in the walls of the ...

Z-pak’s quicker infection cure may equal quicker death

If you’ve ever had a bacterial infection like bronchitis, pneumonia, a sore throat, or an earache, your doctor likely prescribed azithromycin, commonly known as Z-pak. But a new study suggests the popular antibiotic may increase the odds of sudden death in adults, particularly in those with heart disease, diabetes, or those who’ve undergone bypass surgery. Vanderbilt University professor of ...